Liver ablation articles

  1. Todeschini, L, Caimano, M, Mattia, A, Cristin, L, Martinino, A, Bianco, G et al.. Radiofrequency ablation versus surgical resection in colorectal liver metastasis: insight from an umbrella review. Front Oncol. 2025;15 :1494996. doi: 10.3389/fonc.2025.1494996. PubMed PMID:40255430 PubMed Central PMC12006127.
  2. Zhou, J, Qin, S, Cui, R, Chen, Y, Wang, Y, Liu, G et al.. Outcomes of ultrasound-guided percutaneous ablation of >5 versus ≤ 5 colorectal liver metastases: a propensity score matching study. Int J Hyperthermia. 2025;42 (1):2488128. doi: 10.1080/02656736.2025.2488128. PubMed PMID:40255153 .
  3. Katsouda, A, Markou, M, Valakos, D, Theodorou, I, Papapetropoulos, A. Cth/Mpst double ablation results in early onset fatty liver disease in lean mice. Redox Biol. 2025;83 :103641. doi: 10.1016/j.redox.2025.103641. PubMed PMID:40253747 .
  4. Li, B, Li, L, Ren, H. Surgical Resection Versus Microwave Ablation for Colorectal Liver Oligometastases: A Multicenter Cohort Study of 1027 Patients. J Gastrointest Cancer. 2025;56 (1):101. doi: 10.1007/s12029-025-01222-y. PubMed PMID:40244487 PubMed Central PMC12006233.
  5. Lu, H, Xie, X, Zeng, Y, Xia, X, Dong, X, Bu, F et al.. Prognostic Comparison of Complete vs. Incomplete Radiofrequency Ablation for Colorectal Liver Metastases: A Multicenter Prospective Study. Cancer Med. 2025;14 (8):e70735. doi: 10.1002/cam4.70735. PubMed PMID:40231586 PubMed Central PMC11997704.
  6. Anon. Corrigendum for "Radiofrequency ablation with four electrodes as a building block for matrix radiofrequency ablation: Ex vivo liver experiments and finite element method modelling. Influence of electric and activation mode on coagulation size and geometry" by Stefaan Mulier, Ricardo Possebon, Yansheng Jiang, Jacques Jamart, Chong Wang, Yi Miao, Tongfu Yu, Kuirong Jiang, Yuanbo Feng, Guy Marchal, Luc Michel, Yicheng Ni, published in [Surgical Oncol. 33 (2020) 145-157]. Surg Oncol. 2025;60 :102226. doi: 10.1016/j.suronc.2025.102226. PubMed PMID:40228338 .
  7. Franke, J, Rosiak, G, Milczarek, K, Konecki, D, Wnuk, E, Cieszanowski, A et al.. Biomarkers of Survival in Patients with Colorectal Liver Metastases Treated with Percutaneous Microwave Ablation. Cancers (Basel). 2025;17 (7):. doi: 10.3390/cancers17071112. PubMed PMID:40227620 PubMed Central PMC11988189.
  8. Winkelmann, MT, Kübler, J, Gassenmaier, S, Nickel, DM, Ashkar, A, Nikolaou, K et al.. Deep learning-based reconstruction and superresolution for MR-guided thermal ablation of malignant liver lesions. Cancer Imaging. 2025;25 (1):47. doi: 10.1186/s40644-025-00869-x. PubMed PMID:40176185 PubMed Central PMC11966842.
  9. Li, HS, Zhang, XF, Fu, J, Yuan, B. Efficacy of microwave ablation vs laparoscopic hepatectomy for primary small liver cancer: A comparative study. World J Gastrointest Surg. 2025;17 (3):101786. doi: 10.4240/wjgs.v17.i3.101786. PubMed PMID:40162382 PubMed Central PMC11948124.
  10. Fu, X, Gu, L, Xu, J, Li, J. The effect of ultrasound-guided microwave ablation on liver function and short-term efficacy in patients with postoperative recurrence of liver cancer. Curr Probl Surg. 2025;65 :101734. doi: 10.1016/j.cpsurg.2025.101734. PubMed PMID:40128005 .
  11. Gao, W, Zhang, Q, Ma, L, He, N, Zhang, Y, Yuan, C et al.. The Safety Evaluation of TAE for Ruptured Hepatocellular Carcinoma and Ablation-Related Hemorrhage, and the Clinical Significance of Postoperative Liver Function Changes. Transplant Proc. 2025;57 (4):606-611. doi: 10.1016/j.transproceed.2025.02.043. PubMed PMID:40107933 .
  12. Odisio, BC, Albuquerque, J, Lin, YM, Anderson, BM, O'Connor, CS, Rigaud, B et al.. Software-based versus visual assessment of the minimal ablative margin in patients with liver tumours undergoing percutaneous thermal ablation (COVER-ALL): a randomised phase 2 trial. Lancet Gastroenterol Hepatol. 2025;10 (5):442-451. doi: 10.1016/S2468-1253(25)00024-X. PubMed PMID:40090348 .
  13. Burgmans, MC. Software-based quantitative assessment of ablation margins: a new standard for liver tumour ablation. Lancet Gastroenterol Hepatol. 2025;10 (5):403-405. doi: 10.1016/S2468-1253(25)00061-5. PubMed PMID:40090345 .
  14. Abdlaty, R, Abbass, MA, Awadallah, AM. Toward near real-time precise supervision of radiofrequency ablation for liver fibrosis using hyperspectral imaging. Spectrochim Acta A Mol Biomol Spectrosc. 2025;336 :125994. doi: 10.1016/j.saa.2025.125994. PubMed PMID:40086137 .
  15. Qi, XG, Li, JM, Dou, JP, Liu, FY, Wang, Z, Zhang, ZH et al.. Decision-Making for Ablation of Colorectal Liver Oligometastases Patients: A 10-Year Retrospective Study of Survival Outcomes Based on Right-Versus Left-Sided Primary Tumor Location. Cancer Control. 2025;32 :10732748251324627. doi: 10.1177/10732748251324627. PubMed PMID:40085923 PubMed Central PMC11909683.
  16. Rajeev, R, Hussain, HK. Thermal Ablation versus Surgical Resection for Management of Small Colorectal Liver Metastases: Insights from the COLLISION Trial. Radiol Imaging Cancer. 2025;7 (2):e259008. doi: 10.1148/rycan.259008. PubMed PMID:40084950 PubMed Central PMC11966547.
  17. Tawfeeq, HR, Lackey, AI, Zhou, Y, Diolintzi, A, Zacharisen, SM, Lau, YH et al.. Tissue-Specific Ablation of Liver Fatty Acid-Binding Protein Induces a Metabolically Healthy Obese Phenotype in Female Mice. Nutrients. 2025;17 (5):. doi: 10.3390/nu17050753. PubMed PMID:40077623 PubMed Central PMC11901660.
  18. Kong, Y, Huang, X, Cao, X, Tang, F, Zhou, X. Early Recurrence of Colorectal Liver Metastasis (Number ≤ 5 and Largest Diameter ≤ 3 cm) after Resection or Thermal Ablation: a Multi-center Study of Patterns, Safety, Survival and Risk Factors. J Gastrointest Cancer. 2025;56 (1):77. doi: 10.1007/s12029-025-01200-4. PubMed PMID:40072796 .
  19. Kuang, M, Wang, W, Lin, MX, Xie, WX, Xiao, H, Zeng, Y et al.. [Progress in ablation therapy for liver cancer and multidisciplinary application]. Zhonghua Wai Ke Za Zhi. 2025;63 (4):271-275. doi: 10.3760/cma.j.cn112139-20241107-00497. PubMed PMID:40058776 .
  20. Nishi, Y, Sakamoto, K, Uraoka, M, Nagaoka, T, Honjo, M, Tamura, K et al.. Liver resection in patients with a history of local ablation for hepatocellular carcinoma has the risk of poor survival and serosal invasion. Ann Gastroenterol Surg. 2025;9 (2):347-358. doi: 10.1002/ags3.12872. PubMed PMID:40046521 PubMed Central PMC11877331.
Search PubMed

Renal ablation articles

  1. Borghi, C, Bragagni, A. In these cases, I treat hypertension with renal ablation. Eur Heart J Suppl. 2025;27 (Suppl 3):iii32-iii35. doi: 10.1093/eurheartjsupp/suaf012. PubMed PMID:40248286 PubMed Central PMC12001763.
  2. Fisher, G, Kaufman, H, Wilcox, A, Torralba, E, Boldman, E, Boyer, B et al.. Percutaneous Microwave Ablation of Small (<4 cm) Renal Masses Performed Under Moderate Sedation. J Vasc Interv Radiol. 2025; :. doi: 10.1016/j.jvir.2025.03.024. PubMed PMID:40209844 .
  3. Gonçalves, OR, de Melo Neto, AP, Machado Pereira, MAO, Ohannesian, VA, Fernandes, MAN, Dantas, CR et al.. Renal denervation plus cardiac ablation vs. cardiac ablation alone for patients with atrial fibrillation and uncontrolled arterial hypertension : A systematic review and updated meta-analysis of randomized controlled trials. Herz. 2025; :. doi: 10.1007/s00059-025-05302-4. PubMed PMID:40204910 .
  4. Pickersgill, NA. Editorial Comment on "A Randomized Trial of Stereotactic Body Radiation Therapy vs Radiofrequency Ablation for the Treatment of Small Renal Masses: A Feasibility Study (Radster)". Urology. 2025; :. doi: 10.1016/j.urology.2025.04.003. PubMed PMID:40204106 .
  5. Torres, TP, Liakopoulos, I, Balomenos, V, Grigoriadis, S, Papakonstantinou, O, Kelekis, N et al.. Adjunctive techniques for renal cell carcinoma ablation: an update. Front Radiol. 2025;5 :1559411. doi: 10.3389/fradi.2025.1559411. PubMed PMID:40165795 PubMed Central PMC11955682.
  6. Askarpour, M, Aminsharifi, A. Minimally Invasive Salvage Approaches for Management of Recurrence After Primary Renal Mass Ablation. Cancers (Basel). 2025;17 (6):. doi: 10.3390/cancers17060974. PubMed PMID:40149308 PubMed Central PMC11940802.
  7. Chan, VW, Ng, HH, Abdulrauf, K, Zaman, H, Ahmed, A, Zhong, J et al.. Percutaneous Image-Guided Ablation of Renal Cancer: Traditional and Emerging Indications, Energy Sources, Techniques, and Future Developments. Medicina (Kaunas). 2025;61 (3):. doi: 10.3390/medicina61030438. PubMed PMID:40142250 PubMed Central PMC11943572.
  8. Baer, BR, Matheny, MV, Mercedes, RH, Raman, JD. Comparative Analysis of Long-Term Renal Outcomes in Upper Tract Urothelial Carcinoma: Local Ablation Versus Radical Nephroureterectomy. Curr Oncol. 2025;32 (3):. doi: 10.3390/curroncol32030125. PubMed PMID:40136329 PubMed Central PMC11940996.
  9. Travesso, DJ, de Melo, RAB, Almeida, MFA, Motta-Leal-Filho, JM, Moura, EBS, Machado, F et al.. T1b Renal Masses Radiofrequency Ablation: Feasibility, Safety, and Efficacy in Midterm Follow-Up. Int J Urol. 2025; :. doi: 10.1111/iju.70042. PubMed PMID:40062605 .
  10. Cassim, R, Bansal, R, Millan, B, Mironov, O, Ahir, P, Tajzler, C et al.. A Randomized Trial of Stereotactic Body Radiation Therapy vs Radiofrequency Ablation for the Treatment of Small Renal Masses: A Feasibility Study (RADSTER). Urology. 2025; :. doi: 10.1016/j.urology.2025.02.053. PubMed PMID:40058468 .
  11. Schaarschmidt, BM, Zensen, S, Kesch, C, Dertnig, T, Opitz, M, Drews, M et al.. Current use of percutaneous ablation in renal tumors: an analysis of the registry of the German Society for Interventional Radiology and Minimally Invasive Therapy. Eur Radiol. 2025;35 (3):1723-1731. doi: 10.1007/s00330-024-11343-w. PubMed PMID:40016555 PubMed Central PMC11868359.
  12. Carbonara, U, Ditonno, F, Beksac, AT, Derweesh, I, Cerrato, C, Celia, A et al.. Percutaneous Cryotherapy and Radiofrequency Ablation of Renal Masses: Multicenter Comparative Analysis with Minimum 3-Year Follow-up. Int Braz J Urol. 2025;51 (2):. doi: 10.1590/S1677-5538.IBJU.2024.0565. PubMed PMID:39913094 PubMed Central PMC11884627.
  13. Wells, SA, Shapiro, D, Borza, T, Allen, G, Hinshaw, JL, Ziemlewicz, TJ et al.. Percutaneous microwave ablation of cT1b renal cell carcinoma: safety and oncologic efficacy in a large, single-center elderly and comorbid cohort. Abdom Radiol (NY). 2025; :. doi: 10.1007/s00261-024-04794-8. PubMed PMID:39912925 .
  14. Li, G, Chen, Y, Zhang, X. Percutaneous laser ablation vs. radical nephroureterectomy: a comparative study on renal pelvic tumors. Int Urol Nephrol. 2025; :. doi: 10.1007/s11255-025-04395-4. PubMed PMID:39904823 .
  15. Elhakim, TS, Lodhi, T, Fidelis, W, Brea, A, Mort, A, Mohagheghtabar, M et al.. Management of renal cell carcinoma with ablation in comparison to nephrectomy: A 5-year analysis of inpatient procedural data to evaluate utilization disparities in the United States. Clin Imaging. 2025;119 :110412. doi: 10.1016/j.clinimag.2025.110412. PubMed PMID:39862649 .
  16. Ochsner, A, Malshy, K, Golijanin, B, Mega, A, Collins, S, Maxwell, A et al.. Adrenal Metastasis Ablation in Oligometastatic Renal Cell Carcinoma: A Case Series. Clin Genitourin Cancer. 2025;23 (2):102295. doi: 10.1016/j.clgc.2024.102295. PubMed PMID:39854956 .
  17. Justo-Jaume, C, Stempel, M, Qiu, J, Gonzalez Miranda, L, Yan, G, Lyons, G et al.. Efficacy and safety of microwave ablation in solitary kidney patients with T1a small renal masses. Abdom Radiol (NY). 2025; :. doi: 10.1007/s00261-024-04779-7. PubMed PMID:39775024 .
  18. Tyagi, SC. Epigenetics of Homocystinuria, Hydrogen Sulfide, and Circadian Clock Ablation in Cardiovascular-Renal Disease. Curr Issues Mol Biol. 2024;46 (12):13783-13797. doi: 10.3390/cimb46120824. PubMed PMID:39727952 PubMed Central PMC11726923.
  19. Hasegawa, T, Vroomen, LGPH, Sivaraman, A, Fujimori, M, John, NT, Coleman, J et al.. Effect of Transforming Growth Factor-β Inhibition on Ureteral and Renal Scarring in a Rat Model of Upper Urinary Tract Ablation with Irreversible Electroporation. Bioelectricity. 2024;6 (4):272-279. doi: 10.1089/bioe.2024.0022. PubMed PMID:39712219 PubMed Central PMC11656016.
  20. Ravizzini, PI, Lino, HA, Ravizzini, G, Toledo, LGM. Percutaneous radiofrequency ablation of an actively bleeding renal angiomyolipoma. Einstein (Sao Paulo). 2024;22 :eRC1008. doi: 10.31744/einstein_journal/2024RC1008. PubMed PMID:39699407 PubMed Central PMC11634353.
Search PubMed